Pfizer Inc.
Pfizer Global Medical Grants (GMG) supports the global healthcare community’s independent initiatives (e.g., research, quality improvement, or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies. Pfizer’s GMG competitive grant program involves a publicly posted general Request for Proposal (RFP) that provides detail regarding a general area of interest, sets timelines for review and approval, and uses an internal Pfizer review process to make final grant decisions. Organizations are invited to submit an application addressing the research gaps as outlined in the specific RFP.
Research projects that will be considered for Pfizer support will advance the medical knowledge of short stature. Projects submitted may include:
• Morbidities in growth disorders
• Strategies to evaluate and treat growth disorders including Quality of Life and Patient Reported Outcomes
• Comparative pathophysiology of daily vs long-acting growth hormone
• Evaluation of adherence of daily and long-acting growth hormone treatment
• Novel strategies to address current unmet medical needs in short stature management which could be addressed with long-acting growth hormone treatment
• Comparison of clinical effects of daily vs long-acting growth hormone
• Projects may include basic, translational or clinical research
(Note for clinical research studies requesting drug supply: Drug supply refers only to those countries where a drug has regulatory marketing authorization and commercial stock supply is available).
Grant Application due date: Feb. 13, 2023